Skip Navigation
Bookmark and Share
.
Clinical Decision Making
Clinical Decision Making
Prescription drugs are prescribed during clinical encounters. Thorough and effective patient-provider communication about the benefits, risks, costs and alternatives to prescription medicines is a vital part of clinical care. The Center supports research and advocacy to identify and overcome barriers to patient-provider communication to improve safe medication use and to maximize adherence.
Comparative Effectiveness
Comparative Effectiveness
For stakeholders to make informed decisions about prescription drug use, they need timely evidence about the comparative effectiveness of therapies and their alternatives, including their risks and benefits. Incomplete evidence contributes to overuse of some therapies, underuse of others and risky prescribing. The Center supports innovative research into these topics.
Global Medicines
Global Medicines
Ensuring adequate access and affordability of prescription medicines poses major and unique challenges for countries around the world. These challenges are particularly salient in emerging economies that account for an increasing proportion of the world's population and pharmaceutical expenditures. Center investigators focus on how public policy can be optimized to maximize global drug availability and access.
Medication Safety
Medication Safety
Some adverse effects of medicines only come to light after medications have been on the market and widely used. Center investigators are working to develop new methods for identifying risk, to predict the likelihood of high-risk medicines or drug combinations and to protect the public from excessive exposure to these products.
Policy Analyses
Policy Analyses
Complex and dynamic policies govern prescription drug regulation. Policymakers face the challenge of maximizing innovation while protecting public health, and developing payment policies that promote evidence-based usage. Center investigators evaluate regulatory policies to provide policymakers with information to continually optimize pharmaceutical regulation.
Prescription Abuse
Prescription Abuse
Prescription drugs provide therapeutic value to millions of Americans. At the same time, rates of prescription drug abuse and overdose deaths are skyrocketing. The annual number of fatal drug overdoses in the United States now surpasses those of motor vehicle deaths. The Center supports innovative research and public advocacy to help stem this epidemic.

Certificate in Pharmacoepidemiology and Drug Safety

The center is pleased to announce that a Certificate in Pharmacoepidemiology and Drug Safety has been approved by the Bloomberg School of Public Health to begin in the 2014-2015 academic year. The certificate is designed for students at Bloomberg and other Johns Hopkins University divisions, including the Schools of Medicine and Nursing, as well as early and mid-career public health professionals who wish to expand their knowledge of pharmacoepidemiology and drug safety to inform their work in academic, regulatory, or industry settings.

Educational Objectives and Competencies

Upon completion of the core courses required for the Pharmacoepidemiology Certificate, students will have specialized knowledge of the tools and content of pharmacoepidemiology and drug safety.  Participants will have the ability to:

  • Describe the processes of drug development
  • Explain key requirements in biomedical product regulation and their rationale
  • Participate in the design of studies, both observational and experimental, to assess the effectiveness of drugs
  • Employ epidemiological techniques to study the patterns and determinants of drug utilization
  • Apply scientific approaches to examine drug safety, as well as the detection of adverse drug events

For more information about specific courses and to apply, please visit the Bloomberg School of Health's certificate program information page

johns hopkins

.
Subscribe:
  • Receive our Johns Hopkins
    Public Health Magazine,
    Public Health News
.